The pharmacology of Norpace.
D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000097:blood / Q000494:pharmacology*; D001145:Arrhythmias, Cardiac / Q000188:drug therapy*; D001281:Atrial Fibrillation / Q000188:drug therapy; D001282:Atrial Flutter / Q000188:drug therapy; D001283:Atrioventricular Node / Q000187:drug effects*; D001341:Autonomic Nervous System / Q000187:drug effects*; D055598:Chemical Phenomena; D002621:Chemistry; D004206:Disopyramide / Q000097:blood / Q000494:pharmacology* / Q000627:therapeutic use; D004285:Dogs; D004353:Drug Evaluation, Preclinical; D004562:Electrocardiography; D006329:Heart Conduction System / Q000187:drug effects*; D006439:Hemodynamics / Q000187:drug effects*; D007275:Injections, Intravenous; D009203:Myocardial Infarction / Q000150:complications; D011690:Purkinje Fibers / Q000187:drug effects; D011725:Pyridines / Q000494:pharmacology*; D011802:Quinidine / Q000627:therapeutic use
D000889:Anti-Arrhythmia Agents; D011725:Pyridines; D004206:Disopyramide; D011802:Quinidine